CRISM National Section

CRISM Nodes Section

Conferences and Symposia

Pôle Québec

This page showcases the conferences, meetings, and events in which the CRISM Quebec Node has participated, as well as the events we have organized. Explore the presentations, posters, and initiatives shared by our members, and discover how our community contributes to advancing knowledge, fostering collaboration, and promoting innovation in substance use research and practice.

CSAM - SMCA 2024

Canadian Society of Addiction Medicine - La société médicale canadienne sur l'addiction

Oral Presentation

2024 Update of the National Guidelines for the Clinical Management of Opioid Use Disorder
– Ygor Yakovenko PhD RPsych, Yvette Mukaneza PhD, Katuschia Germé PhD, Julie Bruneau MD MSc

 
Lisbon Addictions 2024
 

Oral Presentations

Addressing gender, diversity, and precarity: participatory research to transform addiction services in Canada
– Karine Bertrand, Ph.D.
 
Substance Use, Sexual Pleasure and Recovery among gbMSM: Addressing Sexual Satisfaction in Addiction Interventions
– Blanchette Maxime, Ph.D.
 
Dropout from addiction treatment: predictors, patient profiles, outcomes, and recommendations to improve care
– Marie-Josée Fleury, Ph.D.

Age-related loss of autonomy, residential instability and alcohol use: suggestions to improve intervention and services
– Vincent Wagner, Ph.D.

Increased hepatitis C and HIV incidence among people who inject drugs in Montreal, Canada, 2011-2023
– Sarah Larney, Ph.D.

Gender differences in the hepatitis C cascade of care
– Sarah Larney, Ph.D.

INSHU 2024

Oral Presentation

Global, regional, and country-level estimates of new HCV infections attributed to injection drug use
– Adelina Artenie, Ph.D.

Poster

Global, regional, and country-level estimates of new HCV infections attributed to injection drug use
– Adelina Artenie, Ph.D.

ISSDP 2024

Oral Presentations

For Successful Implementation of Depenalization and Decriminalization in Quebec
– Sandhia Vadlamudy , Julie-Soleil Meeson, Louis Letellier de St-Just

Trends in toxicological findings of unintentional overdose deaths in Quebec, Canada, 2012-2021: Has Quebec entered a new era?
– Sarah Larney, Ph.D.

Harm reduction and pleasure in sexualized substance use interventions
– Maxime Blanchette Ph.D, Mathieu Goyette Ph.D, Karine Bertrand Ph.D, Jorge Flores-Aranda Ph.D

Addiction and
substance use summit

October 26 and 27, 2022 – Université de Sherbrooke, Longueuil Campus, Longueuil, Quebec

Four years after the success of its first edition, the Addiction and Substance Use Summit returned for a second gathering. Nine partners from across the addiction field collaborated to make this second edition possible. The event aligned with the priorities of the Interdepartmental Action Plan on Addiction, which highlights the importance of strengthening knowledge sharing and the exchange of experiences to support their active integration across the addiction sector. Objectives of the Second Summit:

  • Review key developments and achievements since the last Summit (2018);
  • Identify challenges and priorities for the next four years;
  • Inspire participants through the presentation of promising practices, innovative strategies, and solutions to shared challenges;
  • Mobilize participants around common goals and collective action;
  • Inform and support policy reflection among decision-makers.

November 1 and 2, 2018 – Centre Mont-Royal, Montreal, Quebec

Quebec and Atlantic
Node Gatherings

September 27, 2017 – CRCHUM, Montreal, Quebec

Speakers

  • Benedikt Fischer, PhD 
  • Cynthia El Hage PhD 
  • Maykel Ghabrash, MD, MSc
  • Jorge Flores-Aranda, PhD, MSc
  • Kathy Tremblay 
  • Marie-Ève Goyer MD, MSc
  • Sherry Stewart, PhD
  • Tiberiu Mahu
  • Sylvanne Daniels, MSc, PhD

26 septembre 2016 – CRCHUM, Montréal, Québec

Speakers

  • Julie Bruneau
  • Sherry Stewart
  • Didier Jutras-Aswad
  • Michel Perreault
  • Guy-Pierre Levesque
  • Jennifer Swansburg
  • Pascale Desaulniers
  • Mathieu Goyette
  • Jorge Flores-Aranda

Sujet

Soins d'urgence

Décriminalisation

Réduction des méfaits

Application de la loi/Incarcération

Traitement agoniste des opioïdes

Surveillance des ordonnances

Rétablissement

Vérifié par ExactMetrics